Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Karyopharm Therapeut (KPTI)

Karyopharm Therapeut (KPTI)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Karyopharm Therapeut 85 WELLS AVENUE SECOND FLOOR NEWTON MA 02459 USA

P: 617-658-0600

Description:

Karyopharm Therapeutics, Inc. is a clinical-stage pharmaceutical company focused on the discovery and development of drugs for the treatment of cancer and other major diseases. It serves the healthcare industry throughout the United States. Karyopharm Therapeutics, Inc. is based in United States.

Key Statistics

Overview:

Market Capitalization, $K 1,152,403
Shares Outstanding, K 73,122
Annual Sales, $ 40,890 K
Annual Net Income, $ -199,590 K
Last Quarter Sales, $ 18,140 K
Last Quarter Net Income, $ -52,930 K
60-Month Beta 1.44
% of Insider Shareholders 13.26%
% of Institutional Shareholders 92.96%
Float, K 63,426
% Float 86.74%

Growth:

1-Year Return 99.87%
3-Year Return 84.33%
5-Year Return 31.11%
5-Year Revenue Growth 17,678.26%
5-Year Earnings Growth -32.51%
5-Year Dividend Growth 0.00%

Per-Share Information:

Next Earnings Date 08/04/20
Earnings Per Share ttm -2.92
EPS Growth vs. Prev Qtr -2.63%
EPS Growth vs. Prev Year 28.44%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00

KPTI Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward -5.19
Price/Earnings to Growth N/A
Return-on-Equity % -208.07%
Return-on-Assets % -59.78%
Profit Margin % -488.11
Net Margin % N/A
Debt/Equity 0.75
Price/Sales 30.15
Price/Cash Flow N/A
Price/Book 7.42
Book Value/Share 2.27
Interest Coverage -11.75
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar